Timing of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients With Lung Cancer With EGFR Mutations

Article Tools ONCOLOGY GRAND ROUNDS Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2012.43.1858 Journal of Clinical Oncology - published online before print July 2, 2012 PMID: 22753908 Timing of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients With Lung Cancer With EGFR Mutations Teresa MoranxTeresa MoranSearch for articles by this author Lecia V. SequistxLecia V. SequistSearch for articles by this author Show More Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Universitat Autonoma de Barcelona, Barcelona, Spain; Massachusetts General Hospital, Boston, MAMassachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA https://doi.org/10.1200/JCO.2012.43.1858 First Page Full Text PDF Figures and Tables © 2012 by American Society of Clinical Oncology